Communication of Survival Data in US Food and Drug Administration-Approved Labeling of Cancer Drugs.

[1]  L. Trinquart,et al.  Interpretation of time-to-event outcomes in randomized trials: an online randomized experiment , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  Leila C. Kahwati,et al.  Prescribers' Knowledge and Skills for Interpreting Research Results: A Systematic Review , 2017, The Journal of continuing education in the health professions.

[3]  Katherine Karakasis,et al.  Outcomes and endpoints in trials of cancer treatment: the past, present, and future. , 2015, The Lancet. Oncology.

[4]  Steven Woloshin,et al.  The Drug Facts Box: Improving the communication of prescription drug information , 2013, Proceedings of the National Academy of Sciences.

[5]  E. Fotsch.  Electronic Health Records: The New Vehicle for Drug Labeling, Safety, and Efficacy , 2012, Clinical pharmacology and therapeutics.